Local Institution

Brooklyn, New York 11217

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndromes, Bipolar I Disorder, Body Weight Change, Diabetes Mellitus, Non-Insulin-Dependent, HIV Infections, Major Depressive Disorder, Psychotic Disorder, Rheumatoid Arthritis, Schizoaffective Disorder, Schizophrenia

Studies at this site

• A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode — Completed
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder — Completed
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed